Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
Survodutide
1 / 4
Peptide
GLP-1 / Glucagon Dual
SurvodutideOverview
Summary
Dual GLP-1/glucagon agonist — competes with retatrutide on potency.
Category
GLP-1 / Glucagon Dual
Mechanism
Co-agonist of GLP-1 and glucagon receptors — adds energy expenditure on top of appetite suppression.
Effects
Top outcomes
- Fat loss90
Evidence
Emerging
Practical
Half-life
~6-7 days
Administration
subq
Risk
Legal status
research only
Safety
Nausea, vomiting; cardiovascular monitoring required due to glucagon activity.
Try a preset